Related Experiment Video
Updated: Jul 2, 2026
13:17
Cloning and Large-Scale Production of High-Capacity Adenoviral Vectors Based on the Human Adenovirus Type 5
Published on: January 28, 2016
Advances in helper-dependent adenoviral vector research
María M Segura1, Raúl Alba, Assumpció Bosch
1Center of Animal Biotechnology and Gene Therapy (CBATEG), and Department of Biochemistry and Molecular Biology, Universitat Autònoma de Barcelona, Bellaterra 08193, Barcelona, Spain.
Current Gene Therapy
|August 12, 2008
Summary
Helper-dependent adenoviruses offer improved gene therapy potential with reduced toxicity and enhanced transgene expression. These advanced vectors are ideal for delivering large genetic material for treating liver, muscle, and brain diseases.
Area of Science:
- Biotechnology
- Gene Therapy
- Virology
Background:
- Early adenoviral vectors caused immunogenicity and cytotoxicity, limiting their therapeutic use.
- Helper-dependent adenoviruses (HDAdVs) are engineered to lack all viral coding sequences, enhancing safety and efficacy.
Purpose of the Study:
- To review advancements in helper-dependent adenoviral vectors for gene therapy.
- To discuss production, purification, and in vivo applications of HDAdVs.
Main Methods:
- Review of literature on helper-dependent adenoviral vector development.
- Discussion of scalable production, helper virus removal strategies, and chromatography for purification.
- Analysis of in vivo gene delivery and immune system interactions.
Main Results:
- HDAdVs demonstrate reduced toxicity and prolonged high-level transgene expression compared to conventional vectors.
- HDAdVs possess a larger cloning capacity, enabling the transfer of large cDNAs and multiple transgenes.
- Progress in scalable production and purification techniques has been made, though challenges in separating empty particles and helper viruses remain.
Conclusions:
- Helper-dependent adenoviruses represent a promising platform for human gene therapy.
- Further research into immune interactions and optimization of production/purification is crucial for clinical translation.
- HDAdVs show potential for treating diseases of the liver, skeletal muscle, and brain.
